| 000 | 01507 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514001312.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0039-6257 | ||
| 024 | 7 |
_a10.1016/s0039-6257(01)00206-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWheeler, L A | |
| 245 | 0 | 0 |
_aRole of alpha-2 adrenergic receptors in neuroprotection and glaucoma. _h[electronic resource] |
| 260 |
_bSurvey of ophthalmology _cMay 2001 |
||
| 300 |
_aS290-4; discussion S295-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBrimonidine Tartrate |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aIntraocular Pressure |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOcular Hypertension _xmetabolism |
| 650 | 0 | 4 |
_aOptic Nerve Injuries _xmetabolism |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xmetabolism |
| 650 | 0 | 4 |
_aRetina _xmetabolism |
| 650 | 0 | 4 |
_aRetinal Ganglion Cells _xdrug effects |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aGil, D W | |
| 700 | 1 | _aWoldeMussie, E | |
| 773 | 0 |
_tSurvey of ophthalmology _gvol. 45 Suppl 3 _gp. S290-4; discussion S295-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0039-6257(01)00206-5 _zAvailable from publisher's website |
| 999 |
_c11308965 _d11308965 |
||